These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 23847771)

  • 21. Vaccination with proteins involved in tick-pathogen interactions reduces vector infestations and pathogen infection.
    Merino O; Antunes S; Mosqueda J; Moreno-Cid JA; Pérez de la Lastra JM; Rosario-Cruz R; Rodríguez S; Domingos A; de la Fuente J
    Vaccine; 2013 Dec; 31(49):5889-96. PubMed ID: 24084474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Counterattacking the tick bite: towards a rational design of anti-tick vaccines targeting pathogen transmission.
    Rego ROM; Trentelman JJA; Anguita J; Nijhof AM; Sprong H; Klempa B; Hajdusek O; Tomás-Cortázar J; Azagi T; Strnad M; Knorr S; Sima R; Jalovecka M; Fumačová Havlíková S; Ličková M; Sláviková M; Kopacek P; Grubhoffer L; Hovius JW
    Parasit Vectors; 2019 May; 12(1):229. PubMed ID: 31088506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced Transient Immune Tolerance in Ticks and Vertebrate Host: A Keystone of Tick-Borne Diseases?
    Boulanger N; Wikel S
    Front Immunol; 2021; 12():625993. PubMed ID: 33643313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccinomics, the new road to tick vaccines.
    de la Fuente J; Merino O
    Vaccine; 2013 Dec; 31(50):5923-9. PubMed ID: 24396872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Progress on Tick-Borne Animal Diseases of Veterinary and Public Health Significance in China.
    Jia W; Chen S; Chi S; He Y; Ren L; Wang X
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tick saliva in anti-tick immunity and pathogen transmission.
    Kovár L
    Folia Microbiol (Praha); 2004; 49(3):327-36. PubMed ID: 15259776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the tick-pathogen interface for novel control strategies.
    de la Fuente J; Kocan KM; Almazan C; Blouin EF
    Front Biosci; 2008 May; 13():6947-56. PubMed ID: 18508707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of tick-borne diseases.
    Piesman J; Eisen L
    Annu Rev Entomol; 2008; 53():323-43. PubMed ID: 17877457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting arthropod subolesin/akirin for the development of a universal vaccine for control of vector infestations and pathogen transmission.
    de la Fuente J; Moreno-Cid JA; Canales M; Villar M; de la Lastra JM; Kocan KM; Galindo RC; Almazán C; Blouin EF
    Vet Parasitol; 2011 Sep; 181(1):17-22. PubMed ID: 21561715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tick Bioactive Molecules as Novel Therapeutics: Beyond Vaccine Targets.
    Murfin KE; Fikrig E
    Front Cell Infect Microbiol; 2017; 7():222. PubMed ID: 28634573
    [No Abstract]   [Full Text] [Related]  

  • 31. Vaccinomics Approach to Tick Vaccine Development.
    Contreras M; Villar M; Alberdi P; de la Fuente J
    Methods Mol Biol; 2016; 1404():275-286. PubMed ID: 27076305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tick vaccines: current status and future directions.
    de la Fuente J; Contreras M
    Expert Rev Vaccines; 2015; 14(10):1367-76. PubMed ID: 26289976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Perspectives of creation of vaccines against tick bite for nonspecific prophylaxis of vector borne diseases].
    Diatlov IA; Biketov SF; Firstova VV
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (4):101-6. PubMed ID: 21913400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of public health advice about ticks.
    Torres M; Carey V
    N S W Public Health Bull; 2004; 15(11-12):212-5. PubMed ID: 15711617
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tick borne zoonosis: selected clinical and diagnostic aspects].
    Sambri V; Marangoni A; Storni E; Cavrini F; Moroni A; Sparacino M; Cevenini R
    Parassitologia; 2004 Jun; 46(1-2):109-13. PubMed ID: 15305697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translational biotechnology for the control of ticks and tick-borne diseases.
    de la Fuente J
    Ticks Tick Borne Dis; 2021 Sep; 12(5):101738. PubMed ID: 34023540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting a global health problem: Vaccine design and challenges for the control of tick-borne diseases.
    de la Fuente J; Contreras M; Estrada-Peña A; Cabezas-Cruz A
    Vaccine; 2017 Sep; 35(38):5089-5094. PubMed ID: 28780117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ticks and tick-borne pathogens on the rise.
    de la Fuente J; Estrada-Peña A
    Ticks Tick Borne Dis; 2012 Jun; 3(3):115-6. PubMed ID: 22609243
    [No Abstract]   [Full Text] [Related]  

  • 39. A Roadmap for Tick-Borne Flavivirus Research in the "Omics" Era.
    Grabowski JM; Hill CA
    Front Cell Infect Microbiol; 2017; 7():519. PubMed ID: 29312896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subolesin/Akirin vaccines for the control of arthropod vectors and vectorborne pathogens.
    de la Fuente J; Moreno-Cid JA; Galindo RC; Almazan C; Kocan KM; Merino O; Perez de la Lastra JM; Estrada-Peña A; Blouin EF
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():172-8. PubMed ID: 24589118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.